Quintiles Transitional Holdings Inc. (NYSE:Q) had its price target raised by Morgan Stanley from $96.00 to $121.00 in a report issued on Thursday. They currently have an overweight rating on the medical research company’s stock.

Q has been the subject of a number of other reports. Zacks Investment Research upgraded Quintiles Transitional Holdings from a hold rating to a buy rating and set a $101.00 price objective for the company in a research report on Thursday, July 27th. Barclays PLC set a $100.00 price objective on Quintiles Transitional Holdings and gave the company a buy rating in a research report on Friday, August 4th. BidaskClub cut Quintiles Transitional Holdings from a strong-buy rating to a buy rating in a research report on Friday, August 11th. Argus boosted their price objective on Quintiles Transitional Holdings from $98.00 to $104.00 and gave the company a buy rating in a research report on Monday, September 18th. Finally, KeyCorp restated a buy rating and issued a $100.00 price objective on shares of Quintiles Transitional Holdings in a research report on Sunday, September 24th. Eleven investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of $103.15.

Shares of Quintiles Transitional Holdings (Q) traded up $0.54 during trading hours on Thursday, reaching $104.05. The company’s stock had a trading volume of 1,138,100 shares, compared to its average volume of 1,591,800. Quintiles Transitional Holdings has a one year low of $71.90 and a one year high of $110.67. The firm has a market capitalization of $21,987.17, a P/E ratio of 23.76, a PEG ratio of 1.73 and a beta of 0.65. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.22 and a quick ratio of 1.22.

Quintiles Transitional Holdings (NYSE:Q) last announced its quarterly earnings results on Thursday, October 26th. The medical research company reported $1.19 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.14 by $0.05. Quintiles Transitional Holdings had a return on equity of 12.60% and a net margin of 0.58%. The company had revenue of $2.02 billion during the quarter, compared to the consensus estimate of $2.01 billion. During the same period in the previous year, the company posted $1.00 earnings per share. Quintiles Transitional Holdings’s revenue for the quarter was up 77.6% on a year-over-year basis. equities research analysts anticipate that Quintiles Transitional Holdings will post 4.62 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.thecerbatgem.com/2017/11/13/morgan-stanley-increases-quintiles-transitional-holdings-inc-q-price-target-to-121-00.html.

In other Quintiles Transitional Holdings news, major shareholder Cpp Investment Board Private H sold 5,218,245 shares of the company’s stock in a transaction on Monday, August 28th. The stock was sold at an average price of $97.33, for a total value of $507,891,785.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kevin C. Knightly sold 19,339 shares of the company’s stock in a transaction on Friday, August 25th. The shares were sold at an average price of $99.51, for a total value of $1,924,423.89. Following the completion of the sale, the insider now owns 40,650 shares of the company’s stock, valued at $4,045,081.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 14,175,702 shares of company stock valued at $1,361,299,848. 6.40% of the stock is owned by company insiders.

A number of large investors have recently modified their holdings of the business. Vanguard Group Inc. lifted its stake in shares of Quintiles Transitional Holdings by 2.2% in the 2nd quarter. Vanguard Group Inc. now owns 12,789,723 shares of the medical research company’s stock valued at $1,144,680,000 after purchasing an additional 280,893 shares during the last quarter. Longview Partners Guernsey LTD lifted its stake in shares of Quintiles Transitional Holdings by 5.8% in the 3rd quarter. Longview Partners Guernsey LTD now owns 9,218,227 shares of the medical research company’s stock valued at $876,377,000 after purchasing an additional 506,780 shares during the last quarter. Glenview Capital Management LLC lifted its stake in shares of Quintiles Transitional Holdings by 29.3% in the 2nd quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock valued at $798,461,000 after purchasing an additional 2,023,719 shares during the last quarter. Janus Henderson Group PLC lifted its stake in shares of Quintiles Transitional Holdings by 33,092.0% in the 2nd quarter. Janus Henderson Group PLC now owns 6,531,857 shares of the medical research company’s stock valued at $584,601,000 after purchasing an additional 6,512,178 shares during the last quarter. Finally, Macquarie Group Ltd. lifted its stake in shares of Quintiles Transitional Holdings by 1.4% in the 3rd quarter. Macquarie Group Ltd. now owns 1,650,268 shares of the medical research company’s stock valued at $156,903,000 after purchasing an additional 23,376 shares during the last quarter. Institutional investors own 94.04% of the company’s stock.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Stock Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related stocks with our FREE daily email newsletter.